Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Nicole Gonzales

Concepts (305)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
105
4.640
 Why?
Stroke
38
2024
1070
3.590
 Why?
Neurology
5
2024
102
2.370
 Why?
Tissue Plasminogen Activator
23
2024
222
2.230
 Why?
Brain Ischemia
18
2023
321
1.680
 Why?
Fibrinolytic Agents
17
2024
262
1.670
 Why?
Thrombolytic Therapy
14
2024
137
1.530
 Why?
Sexism
1
2024
55
0.850
 Why?
Hematoma
6
2015
53
0.830
 Why?
Ischemic Attack, Transient
1
2023
60
0.810
 Why?
Endarterectomy, Carotid
4
2015
47
0.760
 Why?
Education, Medical
1
2024
244
0.700
 Why?
Platelet Aggregation Inhibitors
3
2022
442
0.700
 Why?
Carotid Stenosis
4
2014
84
0.700
 Why?
Women
1
2020
52
0.680
 Why?
Decompressive Craniectomy
1
2019
8
0.650
 Why?
Time-to-Treatment
2
2021
179
0.620
 Why?
Medicine
1
2020
119
0.610
 Why?
Matrix Metalloproteinases
1
2019
90
0.590
 Why?
Stents
5
2015
502
0.590
 Why?
Mobile Health Units
3
2024
19
0.550
 Why?
Percutaneous Coronary Intervention
1
2022
467
0.550
 Why?
Angioplasty
2
2014
47
0.530
 Why?
Attention
1
2020
438
0.520
 Why?
Brain Injuries
1
2020
466
0.470
 Why?
Aged
39
2024
22032
0.470
 Why?
Emergency Medical Services
5
2024
521
0.460
 Why?
Cerebral Revascularization
1
2014
19
0.460
 Why?
Humans
68
2024
129248
0.440
 Why?
Treatment Outcome
28
2023
10199
0.430
 Why?
Middle Aged
41
2024
31087
0.430
 Why?
Diffusion Tensor Imaging
2
2024
76
0.420
 Why?
Cerebral Ventricles
3
2024
50
0.410
 Why?
Thiazolidinediones
2
2012
137
0.380
 Why?
Hypertension
3
2016
1242
0.370
 Why?
Female
46
2024
68543
0.350
 Why?
Male
48
2024
63501
0.340
 Why?
Health Education
4
2023
334
0.340
 Why?
Disability Evaluation
3
2021
284
0.320
 Why?
Prospective Studies
14
2024
7121
0.310
 Why?
Clinical Trials as Topic
6
2023
1004
0.310
 Why?
Aged, 80 and over
19
2024
7055
0.300
 Why?
Schools
2
2007
439
0.260
 Why?
Awareness
1
2007
99
0.250
 Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
3
0.250
 Why?
Paraneoplastic Syndromes, Nervous System
1
2005
12
0.240
 Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.240
 Why?
Time Factors
11
2019
6543
0.240
 Why?
Risk Factors
9
2022
9745
0.240
 Why?
Anticoagulants
3
2019
636
0.240
 Why?
Healthcare Disparities
2
2024
575
0.230
 Why?
Cerebral Intraventricular Hemorrhage
1
2024
2
0.230
 Why?
Cerebral Blood Volume
1
2024
5
0.230
 Why?
American Heart Association
2
2023
296
0.210
 Why?
Skin Diseases, Vesiculobullous
1
2003
17
0.210
 Why?
Encephalitis, Herpes Simplex
1
2003
21
0.210
 Why?
Herpesvirus 2, Human
1
2003
28
0.210
 Why?
Pilot Projects
5
2023
1584
0.210
 Why?
Pyramidal Tracts
1
2023
26
0.210
 Why?
Hypoglycemic Agents
1
2012
1219
0.210
 Why?
Antihypertensive Agents
3
2016
485
0.210
 Why?
Postoperative Complications
1
2014
2473
0.200
 Why?
Cytochrome P-450 CYP2C19
1
2022
23
0.200
 Why?
Academic Medical Centers
2
2024
474
0.200
 Why?
Ambulances
2
2021
51
0.200
 Why?
Databases, Factual
3
2019
1266
0.190
 Why?
Heterozygote
1
2022
272
0.190
 Why?
PPAR gamma
3
2014
183
0.190
 Why?
Adult
18
2024
35495
0.180
 Why?
Health Promotion
2
2007
719
0.180
 Why?
Neuroprotective Agents
2
2015
122
0.180
 Why?
Faculty, Medical
1
2024
260
0.180
 Why?
Retrospective Studies
15
2019
14455
0.180
 Why?
Anxiety Disorders
1
2023
350
0.170
 Why?
United States
10
2024
13828
0.170
 Why?
Inpatients
1
2024
462
0.160
 Why?
Factor VIIa
2
2011
39
0.160
 Why?
Schools, Medical
1
2020
132
0.160
 Why?
Aspirin
1
2022
380
0.160
 Why?
Predictive Value of Tests
4
2019
1946
0.160
 Why?
Pipecolic Acids
2
2012
25
0.160
 Why?
Overweight
1
2023
531
0.160
 Why?
Recovery of Function
3
2019
641
0.160
 Why?
Prognosis
5
2024
3772
0.150
 Why?
Glasgow Coma Scale
1
2019
165
0.150
 Why?
Adenocarcinoma
1
2005
898
0.150
 Why?
Edema
1
2019
124
0.150
 Why?
Health Services Needs and Demand
1
2020
263
0.150
 Why?
Isoenzymes
1
2019
302
0.150
 Why?
Propensity Score
1
2019
263
0.140
 Why?
Communication
1
2024
836
0.140
 Why?
Disease Progression
3
2013
2630
0.140
 Why?
Dose-Response Relationship, Drug
4
2012
2008
0.140
 Why?
NF-E2-Related Factor 2
2
2015
79
0.140
 Why?
Mexican Americans
2
2009
113
0.140
 Why?
Genotype
1
2022
1835
0.140
 Why?
Sex Factors
3
2019
1965
0.140
 Why?
Hospital Mortality
2
2019
846
0.130
 Why?
Injury Severity Score
1
2019
509
0.130
 Why?
Platelet Transfusion
1
2017
59
0.130
 Why?
Anxiety
1
2023
962
0.130
 Why?
Decision Making
1
2023
849
0.130
 Why?
Severity of Illness Index
8
2024
2737
0.130
 Why?
Ultrasonography, Doppler, Transcranial
3
2013
38
0.130
 Why?
Tomography, X-Ray Computed
4
2021
2515
0.130
 Why?
Texas
4
2013
228
0.120
 Why?
Microglia
2
2008
232
0.120
 Why?
Fumarates
1
2015
8
0.120
 Why?
Quality of Health Care
1
2020
602
0.120
 Why?
Pneumonia, Viral
1
2020
339
0.120
 Why?
Coronavirus Infections
1
2020
333
0.120
 Why?
Antithrombins
2
2013
58
0.120
 Why?
Anti-Inflammatory Agents
2
2011
480
0.120
 Why?
Recombinant Proteins
4
2011
1304
0.120
 Why?
Retinoid X Receptors
1
2014
41
0.120
 Why?
Intraoperative Complications
1
2015
129
0.110
 Why?
Blood Pressure
3
2011
1736
0.110
 Why?
Perioperative Care
1
2015
151
0.110
 Why?
Cerebral Infarction
1
2014
42
0.110
 Why?
Cohort Studies
7
2022
5408
0.110
 Why?
Single-Blind Method
1
2014
271
0.110
 Why?
Neutrophil Infiltration
1
2014
105
0.110
 Why?
Follow-Up Studies
4
2017
4886
0.110
 Why?
Odds Ratio
3
2021
1018
0.100
 Why?
Delivery of Health Care
1
2020
892
0.100
 Why?
Quality Control
1
2013
163
0.100
 Why?
Genetic Predisposition to Disease
1
2021
2276
0.100
 Why?
Sulfonamides
3
2012
495
0.100
 Why?
Medical Records
1
2013
170
0.100
 Why?
Lung Neoplasms
1
2005
2342
0.100
 Why?
Biomarkers
2
2019
3966
0.100
 Why?
Telemedicine
2
2020
789
0.100
 Why?
Exercise
1
2023
1925
0.100
 Why?
Neurosurgical Procedures
1
2013
166
0.090
 Why?
Carotid Artery, Internal
1
2011
41
0.090
 Why?
Cyclooxygenase 2 Inhibitors
1
2011
21
0.090
 Why?
Celecoxib
1
2011
39
0.090
 Why?
Cerebral Amyloid Angiopathy
1
2011
9
0.090
 Why?
Collagen Type IV
1
2011
23
0.090
 Why?
Nervous System Diseases
1
2014
252
0.090
 Why?
Brain Edema
1
2011
60
0.090
 Why?
History, 20th Century
1
2012
291
0.090
 Why?
Carotid Arteries
1
2012
196
0.090
 Why?
NF-kappa B
1
2014
665
0.090
 Why?
Universities
1
2013
407
0.090
 Why?
Injections, Intra-Arterial
4
2013
25
0.090
 Why?
Nephrology
1
2011
60
0.080
 Why?
Risk Assessment
1
2019
3233
0.080
 Why?
Double-Blind Method
2
2012
1875
0.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
22
0.080
 Why?
Treatment Failure
2
2014
339
0.080
 Why?
Heparin
1
2011
253
0.080
 Why?
Resuscitation Orders
1
2009
43
0.080
 Why?
Research Design
2
2013
1043
0.080
 Why?
Health Care Surveys
1
2011
557
0.080
 Why?
Endovascular Procedures
1
2013
301
0.080
 Why?
Venous Thrombosis
1
2011
175
0.080
 Why?
Registries
2
2014
1895
0.080
 Why?
Hand Transplantation
1
2008
9
0.080
 Why?
Intracranial Thrombosis
1
2008
16
0.080
 Why?
Caffeine
1
2009
62
0.080
 Why?
Neutrophils
1
2014
1207
0.070
 Why?
Embolism
1
2008
40
0.070
 Why?
Hand Injuries
1
2008
36
0.070
 Why?
Hypothermia, Induced
1
2009
76
0.070
 Why?
Pyrazoles
1
2011
404
0.070
 Why?
Quality Improvement
1
2016
1095
0.070
 Why?
Surveys and Questionnaires
1
2020
5382
0.070
 Why?
Practice Patterns, Physicians'
2
2017
1267
0.070
 Why?
Renal Dialysis
1
2011
423
0.070
 Why?
Nerve Fibers, Myelinated
1
2005
45
0.060
 Why?
Adolescent
7
2014
20303
0.060
 Why?
Organ Transplantation
1
2008
228
0.060
 Why?
Kidney Failure, Chronic
1
2011
546
0.060
 Why?
Teaching
1
2007
214
0.060
 Why?
Emergency Treatment
1
2006
111
0.060
 Why?
Methylprednisolone
1
2005
83
0.060
 Why?
Emergency Service, Hospital
1
2016
1896
0.060
 Why?
Diffusion Magnetic Resonance Imaging
1
2005
97
0.060
 Why?
Heart Diseases
1
2008
350
0.060
 Why?
Brain Stem
1
2005
98
0.060
 Why?
Paralysis
1
2005
69
0.060
 Why?
Muscle Weakness
1
2005
84
0.060
 Why?
Phagocytosis
3
2014
362
0.060
 Why?
Injections, Intravenous
3
2011
202
0.060
 Why?
Fatal Outcome
1
2005
299
0.060
 Why?
Program Development
1
2007
355
0.060
 Why?
Quality-Adjusted Life Years
1
2024
106
0.060
 Why?
Administration, Intravenous
2
2017
141
0.060
 Why?
Case-Control Studies
3
2021
3377
0.060
 Why?
Ethanol
1
2009
589
0.060
 Why?
Peptides
1
2009
923
0.060
 Why?
Chi-Square Distribution
2
2017
514
0.050
 Why?
Meningitis, Aseptic
1
2003
13
0.050
 Why?
Hemorrhage
2
2023
678
0.050
 Why?
Growth and Development
1
2023
6
0.050
 Why?
Spinal Cord
1
2005
353
0.050
 Why?
Principal Component Analysis
1
2023
190
0.050
 Why?
Certification
1
2023
94
0.050
 Why?
Headache
1
2003
151
0.050
 Why?
Students
1
2007
579
0.050
 Why?
Catalase
2
2014
128
0.050
 Why?
Acute Disease
3
2011
978
0.050
 Why?
Cost-Benefit Analysis
1
2024
569
0.050
 Why?
Brain
1
2014
2669
0.050
 Why?
Respiratory Insufficiency
1
2005
313
0.050
 Why?
Partial Thromboplastin Time
2
2012
52
0.050
 Why?
Reperfusion
2
2013
38
0.050
 Why?
DNA, Viral
1
2003
349
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
947
0.040
 Why?
Macrophages
1
2008
1484
0.040
 Why?
Practice Guidelines as Topic
3
2017
1497
0.040
 Why?
Guideline Adherence
2
2017
526
0.040
 Why?
Hospital Bed Capacity
1
2020
25
0.040
 Why?
Caregivers
1
2007
808
0.040
 Why?
Health Care Rationing
1
2020
57
0.040
 Why?
Ethics, Medical
1
2020
78
0.040
 Why?
Magnetic Resonance Imaging
3
2023
3386
0.040
 Why?
Kaplan-Meier Estimate
2
2012
851
0.040
 Why?
Young Adult
2
2014
12388
0.040
 Why?
Health Resources
1
2020
113
0.040
 Why?
Rats, Sprague-Dawley
2
2015
2396
0.040
 Why?
Logistic Models
2
2017
1984
0.040
 Why?
Combined Modality Therapy
2
2013
1199
0.040
 Why?
Hospitals
1
2023
630
0.040
 Why?
CD36 Antigens
2
2008
36
0.040
 Why?
Arginine
2
2012
265
0.040
 Why?
Ventriculostomy
1
2017
21
0.030
 Why?
Autoantibodies
1
2005
1467
0.030
 Why?
Betacoronavirus
1
2020
248
0.030
 Why?
Statistics, Nonparametric
1
2017
419
0.030
 Why?
Drug Therapy, Combination
2
2012
1040
0.030
 Why?
Longitudinal Studies
1
2023
2716
0.030
 Why?
Rats
2
2015
5482
0.030
 Why?
Disease Models, Animal
3
2014
4057
0.030
 Why?
Dimethyl Fumarate
1
2015
11
0.030
 Why?
Body Mass Index
1
2023
2272
0.030
 Why?
Thrombocytopenia
1
2017
186
0.030
 Why?
Intensive Care Units
1
2020
736
0.030
 Why?
Neuroimmunomodulation
1
2014
69
0.030
 Why?
Biomedical Research
1
2020
637
0.030
 Why?
Perfusion Imaging
1
2014
56
0.030
 Why?
Multivariate Analysis
1
2017
1497
0.030
 Why?
Animals
5
2015
35307
0.030
 Why?
Health Services Accessibility
1
2020
899
0.030
 Why?
Sex Distribution
1
2014
359
0.030
 Why?
Tomography Scanners, X-Ray Computed
1
2012
19
0.030
 Why?
Erythrocytes
2
2008
673
0.020
 Why?
Cerebral Veins
1
2012
15
0.020
 Why?
Pandemics
1
2020
1482
0.020
 Why?
Quality of Life
1
2023
2685
0.020
 Why?
Cerebral Arteries
1
2012
60
0.020
 Why?
Plasminogen Activators
1
2011
7
0.020
 Why?
Mice, Inbred C57BL
2
2015
5439
0.020
 Why?
Heparin, Low-Molecular-Weight
1
2011
29
0.020
 Why?
Radiography
1
2013
794
0.020
 Why?
Obesity
1
2023
2879
0.020
 Why?
Magnetic Resonance Angiography
1
2012
234
0.020
 Why?
Length of Stay
1
2015
1120
0.020
 Why?
Analysis of Variance
1
2013
1288
0.020
 Why?
Mice
3
2015
16915
0.020
 Why?
Life Support Care
1
2009
30
0.020
 Why?
Buspirone
1
2009
4
0.020
 Why?
Meperidine
1
2009
3
0.020
 Why?
Shivering
1
2009
5
0.020
 Why?
Adjuvants, Anesthesia
1
2009
12
0.020
 Why?
Microcirculation
1
2009
145
0.020
 Why?
Microspheres
1
2009
124
0.020
 Why?
Brain Damage, Chronic
1
2008
20
0.020
 Why?
Anti-Anxiety Agents
1
2009
45
0.020
 Why?
Infusions, Intra-Arterial
1
2008
53
0.020
 Why?
Cerebral Angiography
1
2008
108
0.020
 Why?
Mice, Knockout
1
2015
2871
0.020
 Why?
Drug Combinations
1
2009
330
0.020
 Why?
Blood Flow Velocity
1
2009
406
0.020
 Why?
Behavior
1
2008
92
0.020
 Why?
Infusions, Intravenous
1
2008
399
0.020
 Why?
Enzyme Activators
1
2007
7
0.020
 Why?
Deep Brain Stimulation
1
2009
125
0.020
 Why?
Prostaglandin D2
1
2007
22
0.020
 Why?
Cultural Competency
1
2008
82
0.020
 Why?
Regression Analysis
1
2009
991
0.020
 Why?
Urokinase-Type Plasminogen Activator
1
2006
29
0.020
 Why?
Nitric Oxide Synthase Type II
1
2007
171
0.020
 Why?
Graft Survival
1
2008
511
0.020
 Why?
Reproducibility of Results
1
2013
3079
0.020
 Why?
Hydrogen Peroxide
1
2007
317
0.020
 Why?
Recurrence
1
2008
1005
0.010
 Why?
Urban Population
1
2008
441
0.010
 Why?
Graft Rejection
1
2008
598
0.010
 Why?
Animals, Newborn
1
2007
834
0.010
 Why?
Self Efficacy
1
2008
373
0.010
 Why?
Recombinant Fusion Proteins
1
2006
648
0.010
 Why?
Atrial Fibrillation
1
2008
376
0.010
 Why?
Myocardial Infarction
1
2011
1021
0.010
 Why?
Program Evaluation
1
2007
872
0.010
 Why?
Age Factors
1
2009
3140
0.010
 Why?
Curriculum
1
2007
910
0.010
 Why?
Apoptosis
1
2008
2498
0.010
 Why?
Cells, Cultured
1
2007
4076
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2007
1276
0.010
 Why?
Cytokines
1
2007
2013
0.010
 Why?
Parents
1
2007
1308
0.010
 Why?
Neurons
1
2007
1494
0.010
 Why?
Child
1
2007
20773
0.000
 Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (305) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)